What We're Reading: Page 334
Industry reads hand-picked by our editors
Feb 18, 2016
Feb 17, 2016
-
Reuters
Regulus hep C combination drug effective in mid-stage study
-
Stat
Massachusetts drops funding for opioid prescribing program as crisis rages
-
Wall Street Journal
Couple to Give $7.2 Million Toward Efforts to Lower Drug Prices
-
BioSpace
FDA Spurns Merck & Co. (MRK)'s Cardiovascular Claims for Zetia, Vytorin
Feb 16, 2016
Feb 12, 2016
-
Stat News
A reality check on Obama's billion-dollar opioid addiction plan
-
MarketWatch
Valeant uses rare accounting maneuver for acquisitions that cushions income
-
Reuters
WHO sees Zika link proven in weeks as U.S., India lead vaccine race
-
Politico
Troubled health start-up Theranos faces Washington reckoning
Previous
